Head Of PhRMA Says It Would Be Mistake To Think Pelosi’s Aggressive Drug Pricing Bill Won’t Become Reality

Pharmaceutical Research and Manufacturers of America CEO Steve Ubl is treating House Speaker Nancy Pelosi's drug pricing bill like a threat despite doubts that it could make it through the GOP-controlled Senate. “We would like to see a balanced package emerge from the legislative process this year and we’re working both sides of the aisle towards that end," Ubl said.

from Kaiser Health News https://ift.tt/2B5jTyJ